This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 2 EPO patents. Top assignee: Res International Sarl. Active years: 2012.
Company Filing History:
Years Active: 2012
Title: Michael Roth-Chiarello: Innovator in Peptide Therapeutics
Introduction
Michael Roth-Chiarello is a notable inventor based in Sissach, Switzerland. He has made significant contributions to the field of peptide therapeutics, particularly in the treatment of lung diseases. His innovative work has the potential to impact the lives of many suffering from chronic respiratory conditions.
Latest Patents
Roth-Chiarello holds a patent for "Peptides with improved properties having the biological activity of vasoactive intestinal peptide (VIP) and their use for the treatment of lung diseases." This invention relates to novel peptides that exhibit high biological and pharmacological activity as therapeutic agents. These peptides are particularly effective for treating various lung diseases, including chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF), and Bronchiolitis obliterans (BO). The synthetic peptides derived from vasoactive intestinal peptide (VIP) demonstrate enhanced properties compared to VIP itself.
Career Highlights
Throughout his career, Roth-Chiarello has worked with several companies, including Res International Sarl and Ani Biotech Oy. His expertise in peptide research has positioned him as a valuable contributor to the scientific community.
Collaborations
Roth-Chiarello has collaborated with notable professionals in his field, including Mikael Gencay and Jochen Rüdiger. These partnerships have furthered his research and development efforts in peptide therapeutics.
Conclusion
Michael Roth-Chiarello's innovative work in peptide therapeutics showcases his commitment to advancing medical science. His contributions have the potential to improve treatment options for patients with serious lung diseases.